Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Endoscopic Procedures III: Video Capsule Endoscopy01:28

Endoscopic Procedures III: Video Capsule Endoscopy

Capsule endoscopy, or wireless or video capsule endoscopy, is a diagnostic procedure for examining the entire gastrointestinal tract. Patients swallow a capsule about the size of a vitamin tablet. The capsule is equipped with a transmitter, a battery, an LED light source, and a color video camera to capture images throughout the gastrointestinal tract. This procedure is particularly useful for diagnosing conditions such as Crohn's disease, ulcerative colitis, tumors, polyps, ulcers, unexplained...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Anxiety and Depression and Their Impact on the Quality of Life of Cancer Patients Treated with Palliative Antineoplasic Therapy - Results of the PALINT Trial.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019
Same author

Oligometastatic Prostate Cancer.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019
Same author

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX.

Oncology letters·2017
Same author

[Can we Observe Ethnic Difference in Basic Blood Tests? Single-institution Data from Cancer Prevention Programme in the Czech Republic].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2017
Same author

[News in Adjuvant Therapy of Non-seminomatous Germ Cell Testicular Tumors of Stage I].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2016
Same author

[Triple Negative Breast Cancer].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2015
Same journal

68Ga-DOTATOC PET/CT - a case report of synchronous oncological duplicity with high expression of somatostatin receptors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

From progression to complete remission - a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Second and subsequent lines of systemic therapy in endometrial cancer - a real-life clinical experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Clinical presentations of the most common histiocytic disorders.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping
07:47

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Published on: December 15, 2023

[Oncologists use a communication system for videoconferencing]

R Vyzula1

  • 1Klinika komplexní onkologické péce, Masarykův onkologický ustav, Brno. vyzula@mou.cz

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|May 15, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
08:50

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography

Published on: February 9, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping
07:47

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Published on: December 15, 2023

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
08:50

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography

Published on: February 9, 2019